Deutsche Tageszeitung - Quintana's European return delayed by Covid

Quintana's European return delayed by Covid


Quintana's European return delayed by Covid
Quintana's European return delayed by Covid / Photo: © AFP

Former Giro and Vuelta winner Nairo Quintana has been ruled out of next week's Gran Camino race after contracting a bout of Covid, the Colombian announced on Thursday.

Change text size:

Quintana made his return to cycling with Movistar after a doping ban in the Tour Colombia earlier this month, finishing 21st in the 6-stage event.

"I finished the Tour Colombia very sick. I already felt quite bad from the previous days," the diminutive 34-year-old climb specialist said.

Quintana was one of the main attractions for the Gran Camino alongside defending champion and two-time Tour de France winner Jonas Vingegaard (Visma-Lease a Bike) and Olympic champion Richard Carapaz (Education First).

The four-day race begins in the port of La Coruna on February 22 and runs through the rugged Galician hills and Atlantic coastline before finishing in Tui.

Quintana came close to retiring in 2022 when he tested positive for tramadol but made a spectacular return to Spanish team Movistar in October, with whom he won the 2014 Giro and the 2016 Vuelta.

Quintana raced seven seasons with Movistar until 2019, and his return at the head of the team is much anticipated.

"It’s super emotional for me to be back home," said the 1.67-metre climber in January.

"It’s been such a tough year. The sleepless nights, so many days of sacrifice.

"But it was all worth it. I won’t waste this opportunity. I know the values of the team, the values of sport.

"I will give my everything to do things right and I want to help the team achieve the best results."

(T.W.Lukyanenko--DTZ)

Featured

RCSI President Calls for Enhanced Surgical Research Support at Millin Meeting

Professor Michael Kerin, president of the Royal College of Surgeons in Ireland (RCSI), has called for increased support for surgeons to strengthen the nation's surgical research capacity. His remarks preceded the annual Millin Meeting, a gathering of leading healthcare experts focused on integrating innovation and clinical trials into everyday surgical practice.

Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness

Manraj Singh Hans, now seven, was diagnosed with acute lymphoblastic leukemia in February 2023 after a prolonged period during which his early symptoms were repeatedly misdiagnosed as common infections. His parents, Narinder Singh and Parm Hans, initially dismissed signs of illness as winter fatigue before blood in the child’s diaper prompted urgent medical intervention.

American Airlines passenger falls ill and vomits on three travellers

A passenger on board an American Airlines reportedly experienced a medical episode mid-flight A morning flight from Philadelphia to Miami was thrown into disarray after a passenger reportedly vomited over three other travellers.

iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury

Researchers at Keiō University are leveraging induced pluripotent stem (iPS) cells to accelerate drug discovery for rare neurological conditions. Director Okano Hideyuki reports that human-derived cell models have enabled the rapid identification of potential treatments for amyotrophic lateral sclerosis and paved the way for regenerative therapies targeting spinal cord injuries.

Change text size: